Effective September 7, 2022, The Japanese government will stop accepting pre-arrival PCR tests for three times vaccinated travelers.

 

The vaccination certificate is required and must be issued by a government or medical institution which is indicated in Japanese or English. 

 

The certificate must show that the traveler has received a third dose of the COVID vaccine.  The currently accepted vaccinations are listed below:

  1.  COMIRNATY intramuscular injection/Pfizer
  2. Spikevax Intramuscular Injection /Moderna
  3. Nuvaxovid Intramuscular Injection/Novavax
  4. Vaxzevria Intramuscular Injection/AstraZeneca
  5. JCOVDEN intramuscular injection/Janssen
  6. COVAXIN/Bharat Biotech (effective from July 31st, 2022)
    • *Regarding the application of measures based on Japan’s Enhanced Border Measure (28), Comirnaty (manufactured by Fosun Pharma/BioNTech), as well as Covishield and COVOVAX (manufactured by the Serum Institute of India) will be treated as identical to Comirnaty/Pfizer, Vaxzevria/AstraZeneca, and Nuvaxovid/Novavax, respectively.

Please note that this is general information only and not intended as advice on a specific matter. Please feel free to contact Fakhoury Global Immigration directly with questions exclusive to your situation. This news alert may have been prepared using information from Peregrine Immigration Management, which is licensed to Fakhoury Global Immigration.